| Name | Title | Contact Details |
|---|
Invirion Diagonostics is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Accelerated Analytical Laboratories is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Madison Radiology Medical Group is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Natrix Separations is a leading supplier of high performance, single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Natrix Separations’ patented Advective chromatography technology combines the high binding capacity, selectivity and specificity associated with conventional resin-based chromatography with the high throughput and ease-of-use of traditional membrane products. The product consists of a polymeric hydrogel formed within a flexible porous support matrix. The support matrix provides mechanical strength, while the hydrogel properties determine the separation chemistry of the product. The Natrix Chromatography technology now enables single use for primary capture through final polish.
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics` extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation.